LAVCA VC
  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • #changetheratio
  • Engage
    • VC Council
    • VC Members
  • LAVCA
  • Member Login
  • Member Access

LAVCA VC

  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • #changetheratio
  • Engage
    • VC Council
    • VC Members
  • LAVCA

Redpoint Eventures and DNA Capital Invest US$4.5m in Memed

February 20, 2020

Redpoint eventures and DNA Capital, the corporate venture arm of DASA, led a US$4.5m investment in Memed, a Brazilian digital prescription platform. Qualcomm Ventures, monashees and Redpoint invested previously.

(Press Release) Memed raises $4.5 million round from DNA Capital and Redpoint eventures

With the new investment, Brazilian healthtech innovator Memed will expand its leadership role
in digital medical prescriptions.

São Paulo, Brazil – February 20, 2020 – Memed, the market leader in digital medical prescriptions, has just
received a new investment round (Series B), led by DNA Capital , in conjunction with Redpoint eventures, a VC
fund focused on technology startups. The $4.5 million round will be used to boost the transformation of the
traditional scenario of handwritten medical prescriptions into 100 percent digital and intelligent prescriptions
in Brazil, ensuring patient safety and efficiency for doctors, patients and pharmacies. Memed has previously
received funding from some of the main venture capital funds in the region, including Monashees Capital,
Qualcomm Ventures and Redpoint eventures.

According to Ricardo Moraes, Memed’s CEO, the new investment will contribute to the transformation of
medical prescriptions in Brazil. Memed’s vision is to create a digital prescriptions ecosystem that lets patients
leave their doctor’s offices with only the digital version of prescriptions so they can buy medication online or
in person, without the need to present a paper prescription and worry about possible mistakes or
headaches. This process brings more security, intelligence, access to other information and new ability to
find the best prices.

“The path we are following is a long one and it is only possible to reach our goal with the help of the best
partners in the market. We see at DNA Capital , together with current partners, the opportunity to add a
partner with great experience in the health area, opening new doors and accelerating our growth plan in the
market,” said Moraes.

In the view of DNA Capital, this funding represents an important step in the consolidation of Memed as the
main platform for transforming the medical prescription experience. “We thoroughly analyzed the digital
prescription market and were impressed with the quality and vision of Memed’s entrepreneurs. Its trajectory
of innovation will certainly contribute a lot to the sustainability of the sector,” said Pedro Bueno, partner at
DNA Capital.

Manoel Lemos, managing partner at Redpoint eventures, highlights that its fund has been
accompanying Memed since its inception and has participated in all investment rounds.
“We believe in the vision of the founders and in the company they created, and we’re happy to support the
next stage of Memed’s ambitious plan to totally eliminate the use of paper in medical prescriptions in Brazil,
which will accelerate the transformation of the healthcare market, support doctors and improve the
experience of millions of Brazilians,” said Lemos.

As in the previous rounds, Memed remains independent in the implementation of its strategy and now has
more than one important partner in its investor base.
“DNA Capital has acted globally in its practice of venture capital and sees, in this investment, a great
opportunity to transform the health market. Solving the problems related to electronic prescription of
medicines and ensuring that patients can have security in their treatments is a challenging mission and a
great opportunity. Memed is driving the health sector for the future and we want to help it in this process,”
said Luiz Henrique Noronha, partner at DNA Capital.

 

About Memed
Born in Avaré, in the interior of São Paulo, in 2012, Memed built the leading digital medical prescription
platform in Brazil. Dispõe the largest and most current drugs and examination database, combined with clinical
intelligence that helps prevent one drug interacting negatively with another, or even when the patient is
allergic to any active ingredient in prescription drug – all in real time. With more than 80,000 registered doctors,
more than 10 million prescriptions generated and R$ 1.2 billion in prescriptions in 2019 alone, Memed today
acts both through its standalone product, as well as integrations with the largest and most important electronic
medical records in the country, clinics, hospitals and health plans.

 

About DNA Capital
Focused on the healthcare sector, DNA Capital is an investment manager with operations in the venture capital
and private equity segments. With global expertise and leadership in the Brazilian market, the manager
has investments in other large companies in the sector, such as DASA, the largest diagnostics company in Latin
America, Ímpar, a chain of hospitals, and Mafra, the largest distributor of medicines and hospital supplies from
Latin America, in addition to several companies and other geographies, such as
Alto Pharmacy and Clover Health, in the United States. DNA Capital invests globally from its offices in São Paulo
and San Francisco (USA).

About Redpoint eventures
Redpoint eventures is a venture capital firm investing in Latin American startups. The firm partners with
visionary founders using technology to create new markets and solve big problems in existing ones. With an
experienced team in Brazil and in close partnership with two Silicon Valley firms (e.ventures and Redpoint), the
firm help founders secure the capital, talent and growth to succeed further, faster.
Founded in 2012, Redpoint eventures invests across seed, early and growth stages. It manages over $300
million and has more than 40 companies in its portfolio, including Creditas, Gympass, Minuto Seguros, Olist,
Pipefy, Rappi and Resultados Digitais. As part of its mission to support the Brazilian ecosystem, the firm cofounded Cubo (www.cubo.network), the second largest innovation hub in the world, based in Sao Paulo, where
it’s headquartered. For more information, please visit www.rpev.com.br.

Redpoint Eventures and DNA Capital Invest US$4.5m in Memed was last modified: March 3rd, 2020 by Editor
DigitalDNA CapitalHealthtechLuiz Henrique NoronhaManoel LemosMedical PrescriptionsMemedRedpoint eVenturesRicardo MoraesSeries BTechnology
0
Facebook Twitter Google +

Submit VC News

Have private equity or venture capital related news that you would like to share? Submit your press releases and news to news@lavca.org.

Categories

  • Deals
  • Exits
  • Regulatory
  • M&A
  • New Funds & Firms
  • Partnerships

Sector Tags

agribusiness AgTech Artificial Intelligence B2B Big Data biotech Consumer/Retail delivery Digital Media & Entertainment e-commerce ecommerce EdTech Education Energy Financial Services fintech foodtech Healthcare Healthtech HRTECH Human Resources Impact Impact Investing Infrastructure InsurTech IoT IT Logistics & Distribution logistics and distribution marketplace Marketplaces Mobile Private Capital Private Equity Proptech Real Assets Real Estate SaaS Software Startup startups Technology Telecommunications Transportation venture capital

Geography Tags

Alquilando Argentina Argentine Austria Belize Bolivia Brasil Brazil Canada Canary Caribbean Central America Chile Colombia Costa Rica Dominican Republic Ecuador El Salvador Guatemala Honduras India International INTL Israel Jamaica Japan Kenya LatAm Latin America Mexico Miami Nicaragua Pan-Regional Panama Paraguay Peru Portugal Puerto Rico South Korea Spain United States Uruguay US USA Venezuela
LatAm Venture Bulletin

LatAm Venture Bulletin

The LatAm Venture Bulletin is a must-read roundup of startup deals and news on emerging technologies in Latin America, delivered to over 6,000+ investors, entrepreneurs, and corporates bi-weekly.
Asset Class *

Tweets

  • READ latest deal case featuring Aqua Capital's investment in 🇧🇷Brazil-based agribusiness/animal feed additives comp… https://t.co/vAgqJSEPRm

    22-Dec-2020

    Reply Retweet Favorite
  • 🚀LAVCA's #VC #femaleinvestors lists are out: ♀️ Top #Women Investing &⭐Emerging Women Investors in #LatinAmerica… https://t.co/D6bpZqL9LO

    10-Dec-2020

    Reply Retweet Favorite
  • #HappeningNow LAVCA's CEO @ivonnecuello sharing #LatAm #Tech sectors leading, #leapfrogging, & #Socialimpact data.… https://t.co/Bt2sgRQOFm

    11-Nov-2020

    Reply Retweet Favorite
  • 👩‍💻#weXchange2020 LAVCA's Executive Advisor y @CapriaVC 's Venture Partner @RoblesSusanaro y @NXTPvc's Managing Par… https://t.co/F7Fm1EOxZO

    11-Nov-2020

    Reply Retweet Favorite
  • 🔽DOWNLOAD the latest in a series of deal cases featuring LAVCA member Oria Capital's investment in 🇧🇷 software/CPaa… https://t.co/MzKHqR2tnv

    09-Nov-2020

    Reply Retweet Favorite

Keep in touch

Twitter Linkedin Youtube

About LAVCA

 

LAVCA is the Association for Private Capital Investment in Latin America, a not-for-profit membership organization dedicated to supporting the growth of private capital in Latin America and the Caribbean through research, education, networking and advocacy.

LAVCA Offices

    New York City:
    589 8th Ave, 18th Floor
    New York, NY 10018

    Washington DC:
     2600 Virginia Ave. N.W., 500
    Washington, DC 20037

LAVCA Also Has a Regional Presence in:

    Silicon Valley:
    San Francisco, CA

Explore LAVCA.org

  • About LAVCA
  • Board, Team & Councils
  • Media
  • Contact Us
  • Membership Benefits
  • Members Only Access
  • Education and Programs
  • Research
  • Policy
  • LAVCA VC
  • Contact Us

@2020 - LAVCA. All Rights Reserved.


Back To Top